Oogenesis: Building the Egg
A human oocyte sits arrested in a strange kind of suspended animation for up to 50 years. It has been frozen mid-division since before the woman carrying it was born. How does a single cell survive dormant for five decades? How does it then suddenly finish dividing, awaken, and begin building an embryo within hours of fertilization? The answer lies in oogenesis. This process turns an ordinary diploid germ cell into the most metabolically extraordinary cell in the animal body: the egg. Unlike sperm, which are stripped-down delivery vehicles for a haploid genome, eggs must supply almost everything. The early embryo needs ribosomes, mRNAs, proteins, mitochondria, yolk, membrane, and molecular addresses. These addresses will pattern the embryo's body axes. This asymmetry between the gametes is not a detail. It is the reason oogenesis takes years while spermatogenesis takes weeks. Building an egg means stockpiling a lifetime's worth of maternal material into one cell. The cell is then held poised at precise checkpoints in meiosis. It waits until the right signal — often ovulation, then fertilization — tells it to proceed. This matters far beyond reproduction. Certain mechanisms pause meiosis, amplify gene copies to make yolk and ribosomes, and organize cytoplasm into polarized compartments. These are the direct antecedents of the mechanisms that pattern the early embryo. Errors in oogenesis are leading causes of infertility, miscarriage, and aneuploidy syndromes. Such errors include meiotic nondisjunction, defective cytoplasmic maturation, and failure to exit arrest. One example is Down syndrome, whose incidence rises sharply with maternal age. This article works through how the oocyte grows and stockpiles materials. It explains why and how it arrests meiosis not once but twice. It covers the classic experiments — frog oocytes, starfish, and the discovery of MPF — that revealed the molecular switches controlling these arrests. Finally, it shows where these mechanisms surface in the clinic. This includes IVF timing and understanding age-related aneuploidy.
- Oogenesis converts a diploid oogonium into a massively provisioned haploid egg via two meiotic arrests, at prophase I and metaphase II.
- The growing oocyte stockpiles ribosomes, mRNAs, proteins, yolk, and mitochondria, often using gene amplification and help from surrounding follicle/nurse cells.
- Meiotic arrest at prophase I is maintained by high cAMP/PKA activity; a hormone surge (LH) triggers resumption via MPF (Cdk1–cyclin B) activation.
- The second arrest, at metaphase II, is held by cytostatic factor (CSF, based on Emi2) until fertilization triggers a calcium wave that destroys cyclin B and releases arrest.
- Classic experiments — frog oocyte maturation assays, starfish micromanipulation, and cytoplasm-transfer studies — identified MPF and CSF as the physical basis of these arrests.
- Errors in this system (aging oocytes, spindle defects) cause chromosome nondisjunction, the major cause of human trisomies and pregnancy loss.
The egg is built by pausing meiosis at two precisely controlled checkpoints while the cell spends years stockpiling the molecular cargo the future embryo will need before either division is ever completed.
The core idea
Oogenesis is the differentiation pathway that transforms a diploid germ cell, the oogonium, into a mature haploid egg (ovum) competent for fertilization. It differs from spermatogenesis in two fundamental ways. First, division is unequal: each meiotic division produces one large cell retaining nearly all the cytoplasm and one tiny polar body that is essentially discarded, so a single oogonium yields one egg rather than four equal gametes. Second, oogenesis is not a continuous assembly line but a process interrupted by long, regulated pauses called meiotic arrests, during which the cell grows enormously and accumulates maternal stores. The vocabulary matters. An oogonium is the diploid, mitotically proliferating precursor. It enters meiosis and becomes a primary oocyte, which then stalls in prophase I (specifically the diplotene stage, sometimes called the dictyate stage in mammals) — this is the first meiotic arrest, and in humans it can last from before birth until the oocyte is ovulated decades later. During this arrest the primary oocyte is not idle: it grows, often a thousandfold or more in volume, transcribing and stockpiling RNAs and proteins that will not be used until well after fertilization, because the future embryo's own genome is transcriptionally quiet for the first several cell cycles. Upon hormonal stimulation, the primary oocyte resumes meiosis I, extrudes the first polar body, and becomes a secondary oocyte, which promptly arrests again — this time in metaphase II, the second meiotic arrest. It is this metaphase-II-arrested cell that is actually ovulated and fertilized in most animals (though details vary — some invertebrates arrest at prophase I or metaphase I). Fertilization itself is the trigger that finally releases the second arrest, completing meiosis II and extruding the second polar body, leaving a haploid egg pronucleus ready to fuse with the sperm pronucleus. The stockpiling that happens during oocyte growth deserves equal billing with the meiotic choreography, because it is the reason oogenesis exists in this elaborate form at all. The egg must supply ribosomes and tRNAs sufficient for translation through the early rapid, largely transcription-silent cleavage divisions; masked, translationally repressed mRNAs (maternal mRNAs) that will be selectively activated at defined times after fertilization; a full complement of mitochondria (mitochondrial DNA is essentially exclusively maternally inherited); yolk platelets or lipid stores as nutrient reserves, especially critical in non-placental animals; and cytoplasmic determinants — localized molecules that will later inform pattern formation, a topic developed fully in the article on Cytoplasmic Determinants and Egg Polarity. Building this inventory requires mechanisms beyond the oocyte's own transcriptional capacity, which is why many species recruit help — nurse cells, follicle cells, or gene amplification — described below.
Mechanism
Step 1 — Oogonial proliferation and meiotic entry. Primordial germ cells colonize the developing gonad and proliferate mitotically as oogonia. In mammals, essentially all oogonial mitosis and initial meiotic entry happen before birth: oogonia enter meiosis I, become primary oocytes, and progress through leptotene, zygotene, and pachytene — recombination and synapsis occur here — before stalling at diplotene. This is a genuinely conserved feature: unlike males, who continuously produce spermatogonial stem cells throughout adult life, most female mammals are born with their full, non-renewing complement of primary oocytes already arrested in prophase I (roughly 1–2 million in a human newborn, declining through atresia to about 300,000–400,000 by puberty, of which only ~400–500 will ever ovulate across a reproductive lifespan).
Step 2 — The first meiotic arrest: prophase I / dictyate stage. The arrest is maintained by keeping the level of the cyclin-dependent kinase complex MPF (maturation/M-phase promoting factor, Cdk1 bound to cyclin B) below the threshold needed to drive entry into M-phase. The oocyte itself, together with surrounding granulosa/follicle cells, sustains high intracellular cyclic AMP (cAMP), which keeps protein kinase A (PKA) active. Active PKA phosphorylates and inhibits Cdc25 (the phosphatase that would normally activate Cdk1) and activates Wee1/Myt1 (kinases that keep inhibitory phosphates on Cdk1), so Cdk1–cyclin B is held inactive. Gap junctions connecting the oocyte to granulosa cells allow cGMP produced by the follicle cells to diffuse into the oocyte and inhibit the oocyte's own phosphodiesterase (PDE3A), preventing cAMP breakdown — a beautifully simple paracrine circuit that keeps the oocyte locked in prophase I for years.
Step 3 — Oocyte growth and stockpiling. During this long prophase arrest, the primary oocyte undergoes its principal growth phase. Mechanisms of stockpiling vary by lineage but fall into recognizable strategies:
- Autosynthetic growth: the oocyte's own genome, though diploid, transcribes at an elevated rate. In many vertebrate oocytes, lampbrush chromosomes form — meiotic bivalents with extended lateral loops of actively transcribing chromatin, visibly "fluffed out" under the microscope — maximizing RNA output from a single diploid genome.
- Gene amplification: some organisms cannot rely on two genome copies alone. The clearest case is ribosomal RNA gene amplification in amphibian oocytes (studied extensively in Xenopus laevis): the rDNA is selectively replicated extrachromosomally to roughly 1,000–2,000 extra copies, forming hundreds of extra nucleoli, enabling the oocyte to synthesize and store on the order of 10¹² ribosomes — enough to support protein synthesis through early development without any new rRNA transcription.
- Heterosynthetic (nurse-cell-assisted) growth: in many insects (classically Drosophila), each oocyte develops within a cyst connected by cytoplasmic bridges to sister cells that become polyploid nurse cells rather than gametes. The nurse cells amplify their own genomes and manufacture bulk mRNA and protein, which is dumped into the oocyte through the bridges — the oocyte essentially outsources its factory to disposable diploid (or polyploid) siblings.
- Vitellogenesis: in egg-laying (oviparous) animals, yolk proteins are not made by the oocyte at all but synthesized in the liver (vitellogenin) or fat body, secreted into the blood/hemolymph, and taken up by the oocyte via receptor-mediated endocytosis, then cleaved and packaged into yolk platelets. This is under hormonal control (estrogen in vertebrates) and can increase oocyte volume enormously — a full-grown Xenopus oocyte reaches roughly 1.2 mm in diameter, about 100,000 times the volume of a typical somatic cell.
Step 4 — Hormonal trigger and meiotic resumption (maturation). In vertebrates, a surge of luteinizing hormone (LH) from the pituitary acts on follicle cells, which lowers cGMP delivery to the oocyte (partly by reducing gap-junction communication and by degrading the enzyme that makes cGMP). Falling cGMP allows PDE3A to become active, cAMP falls, PKA activity drops, and the brakes on Cdk1 are released: Cdc25 becomes active, Wee1/Myt1 are inactivated, and Cdk1–cyclin B (MPF) activity spikes. MPF activation drives nuclear envelope breakdown (historically visible as "germinal vesicle breakdown," GVBD), chromosome condensation, and spindle assembly — the oocyte resumes and completes meiosis I. Because division is asymmetric, one set of chromosomes is expelled into a small first polar body while the oocyte retains the cytoplasm. The cell immediately proceeds into meiosis II without an intervening S phase or nuclear envelope reformation, and arrests again — now at metaphase II.
Step 5 — The second meiotic arrest: metaphase II and cytostatic factor (CSF). This second arrest is held by CSF activity, whose central molecular player is Emi2 (also called Erp1), an inhibitor of the anaphase-promoting complex/cyclosome (APC/C). Because the APC/C is what normally triggers cyclin B degradation and anaphase, keeping APC/C inhibited via Emi2 freezes the cell at metaphase II with high, stable Cdk1–cyclin B activity — the cell is mechanically ready to divide but molecularly forbidden from doing so. (An earlier model held that Mos-activated MAPK signaling was itself the CSF activity; the modern consensus, refined substantially since the discovery of Emi2 in the early 2000s, is that Mos–MAPK signaling acts mainly upstream to stabilize and activate Emi2, which is the direct APC/C inhibitor.)
Step 6 — Fertilization releases the arrest. Sperm entry triggers a transient rise in intracellular free calcium in the egg — in most species a propagating calcium wave, in mammals a series of repetitive calcium oscillations driven by sperm-delivered phospholipase C zeta (PLCζ), which generates IP₃ and releases Ca²⁺ from the egg's endoplasmic reticulum. Calcium activates calmodulin-dependent protein kinase II (CaMKII), which phosphorylates and marks Emi2 for degradation. With Emi2 destroyed, the APC/C is freed to ubiquitinate cyclin B, the proteasome degrades cyclin B, Cdk1–cyclin B (MPF) activity collapses, and the cell completes meiosis II — extruding the second polar body and leaving a haploid egg pronucleus. This handoff from egg-cell-cycle machinery to embryonic development is elaborated further in Fertilization: Sperm-Egg Recognition and Fusion.
The evidence
Discovering MPF: frog oocyte cytoplasm-transfer experiments. In 1971, Yoshio Masui and Clement Markert working with Xenopus laevis oocytes made the discovery that named the whole field of cell-cycle regulation. Immature frog oocytes are arrested in prophase I and can be induced to mature (undergo GVBD and arrest at metaphase II) by treating them with the hormone progesterone. Masui and Markert took cytoplasm from a progesterone-matured oocyte (already arrested at metaphase II) and microinjected a tiny volume into an untreated, immature prophase-I oocyte that had received no hormone at all. The recipient oocyte underwent germinal vesicle breakdown and matured to metaphase II — without ever seeing progesterone. This proved that maturation was driven by a diffusible, transferable cytoplasmic activity, not simply a direct hormonal effect on the nucleus; they named this activity maturation-promoting factor (MPF). Serial transfer experiments showed the activity could be passed from oocyte to oocyte indefinitely, and critically, MPF activity itself oscillated — rising as cells entered M-phase and falling as they exited — which decades later, once cyclins and Cdks were identified biochemically (work substantially advanced by Tim Hunt's discovery of cyclin in sea urchin and clam embryos, and by studies in yeast by Paul Nurse and Leland Hartwell identifying Cdc2/Cdk1), was shown to be the universal cell-cycle engine: MPF is Cdk1 bound to cyclin B, and this trio's work was recognized with the 2001 Nobel Prize in Physiology or Medicine to Hartwell, Hunt, and Nurse. The frog oocyte assay remains a textbook demonstration that a cytoplasmic factor, not merely a signal received at the nucleus, controls the decision to enter M-phase — precisely the logic needed to explain how an egg's cytoplasm can hold a nucleus in arrest for years and then release it in minutes.
Discovering CSF: the starfish/frog egg-fusion and cytoplasm-transfer experiments. The second arrest posed a distinct puzzle: unfertilized eggs sit at metaphase II with high MPF activity, yet MPF activity must eventually fall for anaphase to occur — so what keeps MPF high, unfertilized, indefinitely? Masui and Markert's original 1971 paper also addressed this: they took cytoplasm from an unfertilized, metaphase-II-arrested frog egg and injected it into one blastomere of an early two-cell frog embryo (a cell actively cycling through mitosis). The recipient blastomere arrested in metaphase, its own cell cycle halted by the injected material, while its sister blastomere continued dividing normally. This showed the metaphase-II egg contains a diffusible activity capable of imposing metaphase arrest on an otherwise cycling cell; they termed this cytostatic factor (CSF). For three decades the molecular identity of CSF was contested, with the Mos–MAPK–p90Rsk pathway proposed as a leading candidate (Mos-deficient mouse oocytes fail to arrest properly at metaphase II and instead undergo parthenogenetic-like activation). The modern resolution came in the early 2000s when several groups (including work from the Yang laboratory identifying Emi2/Erp1) showed that Emi2 is the direct inhibitor of the APC/C and the proximal CSF activity, with Mos–MAPK signaling acting upstream to stabilize Emi2. Depleting Emi2 from arrested eggs causes them to exit metaphase II spontaneously, and adding back stabilized (non-degradable) Emi2 after fertilization blocks the normal calcium-triggered release from arrest — direct, causal evidence that Emi2 is what CSF actually is at the molecular level.
Confirming the calcium trigger. Independent classic work (beginning with Lionel Jaffe's studies of fertilization potentials and calcium imaging in the 1970s–80s, extended by microinjection experiments) showed that injecting calcium ionophores or calcium itself into an unfertilized metaphase-II egg is sufficient to trigger the same exit from arrest, second polar body extrusion, and pronuclear formation seen at normal fertilization — even with no sperm present. Conversely, buffering intracellular calcium (injecting calcium chelators such as BAPTA) blocks activation even when sperm do fuse with the egg. This is decisive, complementary evidence: calcium is both necessary and sufficient to release the metaphase-II arrest, cementing the causal chain from sperm fusion through calcium release through Emi2 destruction to resumption of meiosis.
Worked examples
Example 1 — Counting nucleoli and ribosome economics in a Xenopus oocyte. A stage VI Xenopus laevis oocyte is roughly 1.2 mm in diameter. Its diploid genome carries only two chromosomal loci encoding rRNA genes, yet the oocyte nucleus (germinal vesicle) contains on the order of 1,000 extrachromosomal nucleoli, each independently transcribing rRNA. Suppose each nucleolus, over the multi-month growth period, produces roughly 10⁹ ribosomes (a simplified but realistic order-of-magnitude figure). Total ribosome stockpile: 1,000 nucleoli × 10⁹ ribosomes ≈ 10¹² ribosomes — matching the widely cited estimate for a mature Xenopus egg. Now compare this to a typical somatic cell, which might contain on the order of 10⁷–10�sup>8 ribosomes. The oocyte therefore stockpiles roughly 10,000-fold more ribosomes than an ordinary cell — not because its genome is larger, but because it has amplified its rRNA-gene copy number roughly 500- to 1,000-fold above the two-copy diploid baseline. This explains, mechanistically, how the embryo can undergo roughly a dozen extremely rapid cleavage divisions after fertilization, each producing two daughter cells that must be supplied with a full complement of translation machinery, without transcribing a single new ribosomal gene until the mid-blastula transition, when the embryo's own genome finally activates.
Example 2 — Reasoning through why maternal age raises trisomy risk. A 25-year-old woman and a 42-year-old woman are each having an oocyte examined for meiotic spindle integrity. Recall that in humans, all primary oocytes complete prophase I arrest before birth, and each egg then sits arrested — with its cohesin-linked bivalent chromosomes literally physically tethered by cohesin protein complexes deposited before birth — until it is finally ovulated, possibly 40+ years later. Cohesin, unlike most proteins, is not resynthesized in non-dividing arrested oocytes; the cohesin holding sister chromatids and homologs together must last the entire arrest period. Over decades, cohesin complexes degrade or are lost without replacement, weakening the physical linkage between homologous chromosomes. When the LH surge finally triggers meiosis I resumption, weakened cohesin makes it more likely that a bivalent will separate prematurely or that a lagging chromosome will be misassigned during segregation — nondisjunction. This directly predicts, and matches, the observed clinical relationship: trisomy 21 (Down syndrome) live-birth incidence is roughly 1 in 1,500 for mothers around age 20, rising to roughly 1 in 100 (or higher) by age 40 — because the oocytes ovulating in a 40-year-old have been arrested in prophase I, cohesin decaying the entire time, for about twice as long as those ovulating from a 20-year-old. The mechanism (a decades-long, non-renewable meiotic arrest) and the clinical epidemiology (rising trisomy risk with maternal age) fit together as cause and consequence.
Common misconceptions & traps
| Misconception | Why it's wrong |
|---|---|
| "Oogenesis produces four eggs per oogonium, like spermatogenesis produces four sperm." | Divisions are cytoplasmically asymmetric; most cytoplasm stays with one cell each round. One oogonium yields one functional egg plus two or three small polar bodies that normally degenerate. |
| "The egg is ovulated already haploid and 'finished'." | In humans and most vertebrates, the ovulated egg is arrested at metaphase II, meiosis is NOT complete, and the second polar body is only extruded after (or as part of) fertilization. |
| "The oocyte is transcriptionally and metabolically dormant during its long arrest." | The opposite is true: prophase-I arrest is precisely when the oocyte does most of its growing, transcribing lampbrush chromosomes, amplifying rDNA, or importing nurse-cell/yolk products — arrest pauses the chromosome cycle, not gene expression or growth. |
| "Meiotic arrest is a passive default state that just happens when a cell isn't stimulated." | Both arrests are actively maintained by specific signaling (cAMP/PKA at prophase I; Emi2/CSF at metaphase II) and require continuous molecular enforcement — removing the responsible protein causes spontaneous exit from arrest. |
| "Calcium triggers fertilization; MPF/cyclin degradation is a separate, unrelated event." | They are one causal chain: calcium → CaMKII → Emi2 phosphorylation/degradation → APC/C activation → cyclin B destroyed → Cdk1 (MPF) inactivated → arrest released. |
The scientist behind it
Origins · 1 minYoshio Masui and how this was discovered
Yoshio Masui trained in Japan before moving to North America, where his work with Xenopus laevis oocytes in the late 1960s and early 1970s transformed cell-cycle biology from a descriptive to a mechanistic science. Working alongside Clement Markert at Yale, Masui devised the cytoplasm-transfer assay that revealed MPF, then followed it with the CSF-transfer experiments that explained metaphase-II arrest — two discoveries from a single elegant experimental system that together explain both meiotic pauses covered in this article. Masui continued this line of work at the University of Toronto, and his identification of MPF is now recognized as the founding observation that led, via subsequent biochemical work by Tim Hunt (cyclins) and the genetics of Paul Nurse and Leland Hartwell (Cdc2/Cdk1 in yeast), to the modern molecular model of the eukaryotic cell cycle honored by the 2001 Nobel Prize.
Where this matters today
Understanding oocyte arrest and maturation underlies nearly every technology in modern assisted reproduction. In IVF, drugs (gonadotropins) are timed precisely to mimic the natural LH surge, driving oocytes from prophase-I arrest to metaphase-II arrest (in vitro maturation) at a controlled moment so retrieval can be scheduled; ICSI (intracytoplasmic sperm injection) works only because clinicians know an injected metaphase-II egg will respond to the calcium signal analogous to natural sperm entry, releasing CSF-mediated arrest. Human oocyte cryopreservation (egg freezing), now widely used for fertility preservation before chemotherapy or for elective delayed childbearing, exploits the fact that a metaphase-II-arrested egg is a stable, storable cell state precisely because its cell cycle is molecularly frozen by Emi2/CSF activity even at normal temperatures, and can be reliably reactivated on thaw. Research into the age-dependent decay of cohesin during the decades-long prophase-I arrest has directly informed clinical counseling about maternal-age-related aneuploidy risk and has motivated screening strategies such as preimplantation genetic testing for aneuploidy (PGT-A). In livestock and conservation biotechnology, in vitro maturation of oocytes collected from ovaries (including from endangered species) depends entirely on replicating the cAMP/PKA and MPF signaling switches described here to produce mature, fertilizable eggs outside the body. Finally, basic understanding of maternal mRNA stockpiling and translational masking — the topic that leads directly into Cytoplasmic Determinants and Egg Polarity — has informed model systems for studying human oocyte-factor mutations that cause "oocyte maturation arrest" infertility, a clinical condition now traced in some families to mutations in genes such as TUBB8 and PATL2 that disrupt exactly the spindle and mRNA-masking machinery built during the growth phase described in this article.
Ask the tutor: How exactly does the calcium oscillation pattern triggered by sperm entry differ across species, and why does mammalian fertilization use repetitive Ca²⁺ spikes rather than a single wave?
Why does the egg need to arrest meiosis at all — why not just finish dividing and wait as a haploid cell?
Arresting before completing meiosis lets the cell remain diploid (or nearly so) during its long growth phase, which matters because DNA repair, recombination-associated chromosome stability, and gene dosage are safer with two genome copies present. More practically, arresting at metaphase II keeps the cell poised with a fully assembled spindle and condensed chromosomes, ready to segregate immediately upon a single fertilization signal, avoiding the need to reassemble spindle machinery under time pressure. Prophase-I arrest, meanwhile, is the period when the bulk of RNA, protein, and organelle stockpiling occurs — completing meiosis earlier would not change what's being stockpiled, but arresting gives precise hormonal control over exactly when the egg becomes competent for fertilization, synchronizing ovulation with ovarian cycle events.
Are polar bodies completely useless, or do they do anything?
Polar bodies are the discarded haploid products of the two unequal meiotic divisions in the female germline; they receive a full haploid chromosome set but almost no cytoplasm, and in most species they degenerate without further function. They are not entirely without biological interest, though: in clinical embryology, first and second polar bodies are sometimes biopsied and genetically screened as a proxy for the oocyte's own chromosome complement (since they are complementary meiotic products), used in preimplantation genetic testing without disturbing the actual egg or embryo. In a few unusual cases across the animal kingdom, polar-body nuclei have been experimentally manipulated to generate gynogenetic or parthenogenetic offspring, but under normal development they simply degrade.
How is oogenesis different from spermatogenesis in terms of timing and cell output?
Spermatogenesis is continuous and prolific: spermatogonial stem cells divide throughout adult male life, and each primary spermatocyte yields four equal, motile sperm over a cycle lasting about 64–74 days in humans. Oogenesis is discontinuous and conservative: essentially all oocytes are produced before birth, arrested for years to decades, and each primary oocyte yields only one large egg (plus non-functional polar bodies) via two grossly asymmetric divisions. The asymmetry reflects a fundamentally different design goal — sperm are optimized for numbers and motility to reach the egg, while eggs are optimized to supply cytoplasmic bulk and stored materials sufficient for a whole embryo's initial development.
What actually goes wrong in "oocyte maturation arrest," a real cause of human infertility?
Some women's oocytes fail to progress past germinal vesicle breakdown or fail to assemble a normal metaphase spindle, so they never reach a fertilizable metaphase-II state even after hormonal stimulation in IVF cycles. Genetic studies have identified causative mutations in genes including TUBB8 (a tubulin isoform essential for oocyte-specific spindle assembly) and PATL2 (an RNA-binding protein involved in the translational masking of stored maternal mRNAs). These findings connect directly to the mechanisms in this article: TUBB8 mutations disrupt the physical spindle machinery needed to execute the meiotic divisions once arrest is released, while PATL2 mutations disrupt the stockpiling and controlled release of maternal mRNA that the oocyte accumulated during its growth phase.
Does the mother's mitochondrial DNA in the egg matter for inheritance?
Yes — because sperm contribute essentially no functional mitochondria to the zygote (the few sperm mitochondria that do enter are typically actively degraded, via ubiquitin-tagging, soon after fertilization), the egg's stockpile of mitochondria, accumulated during oocyte growth, becomes nearly the entire mitochondrial population of the resulting individual. This is why mitochondrial DNA is used as a maternal-lineage marker in population genetics and forensic identification, and why mitochondrial diseases caused by mtDNA mutations are inherited exclusively through the maternal line. It is also the basis for experimental "mitochondrial replacement therapy" (sometimes called three-parent IVF), which transfers a nuclear genome into a donor egg with healthy mitochondria to prevent transmission of maternal mitochondrial disease.
Why does the size difference between egg and sperm matter developmentally, not just numerically?
The volume difference is enormous — a human egg is roughly 100 micrometers in diameter versus a sperm head around 5 micrometers — and that bulk is not incidental packaging but the actual working inventory for early development. Cleavage-stage embryos in most animals divide rapidly with little or no new transcription, relying entirely on maternally supplied ribosomes, mRNAs, and proteins made during oogenesis; without this stockpile, the embryo would have nothing to translate before its own genome activates at the maternal-to-zygotic transition. The size asymmetry is thus a direct physical signature of the division of reproductive labor: sperm deliver a genome and trigger, while eggs deliver the entire initial operating budget of the embryo.
How does this connect to what happens right after fertilization, in terms of the embryo's body axes?
During oocyte growth, cytoplasmic components — including localized mRNAs, protein complexes, and cortical cytoskeletal elements — are often deposited in specific regions of the oocyte rather than distributed uniformly, setting up an animal–vegetal axis or other polarity cues well before fertilization occurs. These pre-positioned cytoplasmic determinants are inherited by specific blastomeres during cleavage and can influence which genes are activated in which cells, becoming the earliest asymmetries the embryo possesses. This sets the stage directly for the article on Cytoplasmic Determinants and Egg Polarity, where the molecular identity and function of these localized maternal factors — and how their asymmetric inheritance biases early cell fates — is examined in detail.